Barclays
CLMT icon

Barclays’s Calumet Specialty Products CLMT Stock Holding History

Barclays’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,000
Closed -$11K – 5635
2020
Q1 		$11K Sell
10,000
-100
-1% -$338 ﹤0.01% 5790
2019
Q4 		$37K Sell
10,100
-20,500
-67% -$70.8K ﹤0.01% 5832
2019
Q3 		$111K Sell
30,600
-3,700
-11% -$15.8K ﹤0.01% 5394
2019
Q2 		$144K Buy
34,300
+9,600
+39% +$38.4K ﹤0.01% 5393
2019
Q1 		$88K Buy
24,700
+5,900
+31% +$19.6K ﹤0.01% 5459
2018
Q4 		$42K Sell
18,800
-112,400
-86% -$464K ﹤0.01% 5557
2018
Q3 		$840K Sell
131,200
-20,200
-13% -$143K ﹤0.01% 3802
2018
Q2 		$1.13M Sell
151,400
-3,200
-2% -$24.1K ﹤0.01% 3152
2018
Q1 		$1.09M Buy
154,600
+86,000
+125% +$636K ﹤0.01% 3102
2017
Q4 		$528K Buy
68,600
+54,100
+373% +$451K ﹤0.01% 3770
2017
Q3 		$121K Buy
14,500
+14,200
+4,733% +$88.5K ﹤0.01% 4794
2017
Q2 		$1K Sell
300
-5,800
-95% -$23.3K ﹤0.01% 6494
2017
Q1 		$23K Sell
6,100
-1,900
-24% -$7.52K ﹤0.01% 5738
2016
Q4 		$32K Sell
8,000
-3,100
-28% -$12.6K ﹤0.01% 5410
2016
Q3 		$50K Buy
11,100
+8,300
+296% +$42.7K ﹤0.01% 4969
2016
Q2 		$14K Sell
2,800
-1,000
-26% -$5.67K ﹤0.01% 5415
2016
Q1 		$42K Buy
3,800
+2,800
+280% +$38.9K ﹤0.01% 4871
2015
Q4 		$19K Hold
1,000
– – ﹤0.01% 5200
2015
Q3 		$24K Sell
1,000
-11,700
-92% -$304K ﹤0.01% 5366
2015
Q2 		$318K Buy
12,700
+6,300
+98% +$167K ﹤0.01% 3819
2015
Q1 		$154K Sell
6,400
-2,900
-31% -$73.4K ﹤0.01% 4538
2014
Q4 		$205K Buy
9,300
+5,200
+127% +$135K ﹤0.01% 4615
2014
Q3 		$111K Buy
4,100
+2,100
+105% +$63.5K ﹤0.01% 5240
2014
Q2 		$62K Sell
2,000
-8,500
-81% -$253K ﹤0.01% 5788
2014
Q1 		$263K Sell
10,500
-17,100
-62% -$467K ﹤0.01% 4533
2013
Q4 		$718K Sell
27,600
-1,800
-6% -$50.3K ﹤0.01% 3733
2013
Q3 		$794K Buy
29,400
+13,200
+81% +$415K ﹤0.01% 3606
2013
Q2 		$589K Buy
+16,200
New +$582K ﹤0.01% 4019

Other funds holding CLMT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
Tyro Capital Management
Tyro Capital Management Miami, Florida $564M AUM 72.37% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Barclays's CLMT Position: Q3 2026 in Review

Barclays increased its Calumet Specialty Products (CLMT) stake by 3.9% in Q3 2026, buying an estimated $2.62M and bringing the position to 1,465,182 shares worth $76.7M. The position accounts for 0.02% of the portfolio, ranked #600.

Barclays first reported a position in CLMT in Q2 2013 and has held it in 50 quarters since. 174 funds tracked by Wall St. Rank hold CLMT as of Q3 2026.

  • Barclays held 1,465,182 shares of Calumet Specialty Products worth $76.7M as of Q3 2026.
  • Barclays bought 55,409 Calumet Specialty Products shares in Q3 2026, an estimated $2.62M.
  • Calumet Specialty Products made up 0.02% of Barclays's portfolio in Q3 2026, its #600 holding.
  • Barclays first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 50 quarters since.
  • 174 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.